TABLE 4.
Format | Genotype | Log10 measured concentration − log10 expected concentrationa (IU/ml)
|
||
---|---|---|---|---|
3.5 log10 | 4.5 log10 | 5.5 log10b | ||
COBAS AMPLICOR | 1a | 0.2 | 0.1 | −0.1 |
1b | 0.3 | 0.2 | 0.1 | |
2a | 0.4 | 0.4 | 0.1 | |
2b | 0.2 | 0.1 | −0.1 | |
3a | 0.0 | 0.0 | −0.2 | |
AMPLICOR | 1a | 0.2 | 0.0 | −0.2 |
1b | 0.3 | 0.2 | 0.1 | |
2a | 0.4 | 0.3 | 0.0 | |
2b | 0.4 | 0.2 | −0.1 | |
3a | −0.1 | −0.2 | −0.3 |
High-concentration clinical specimens were diluted to the indicated log10 concentration (international units per milliliter). For each sample, results for six replicates were averaged and log10-transformed prior to calculating the difference between the measured and expected log10 titers. The expected concentration was originally measured by performing both the COBAS AMPLICOR and AMPLICOR HCV MONITOR v2.0 tests on a sample of the original specimen that was diluted to achieve a concentration near the middle of the linear range.
For genotype 1b only, the input concentration was 5.2 log10 IU/ml.